Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
Authors
Keywords
Cannabidiol, Hypertension, Cannabinoid receptor, Isolated heart, Isolated atrium
Journal
TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 411, Issue -, Pages 115368
Publisher
Elsevier BV
Online
2020-12-17
DOI
10.1016/j.taap.2020.115368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
- (2020) Salahaden R. Sultan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol protects against high glucose‐induced oxidative stress and cytotoxicity in cardiac voltage‐gated sodium channels
- (2020) Mohamed A. Fouda et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy
- (2020) Chike C. Nwabuo et al. CURRENT HYPERTENSION REPORTS
- Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
- (2020) Patryk Remiszewski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
- (2020) Christopher S. Pauli et al. Frontiers in Pharmacology
- The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies
- (2020) Vivian Tran et al. Frontiers in Pharmacology
- From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
- (2020) Tommaso Cassano et al. Frontiers in Pharmacology
- Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
- (2020) Rafael G. Dos Santos et al. Expert Opinion on Drug Metabolism & Toxicology
- Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
- (2020) Edward Chesney et al. NEUROPSYCHOPHARMACOLOGY
- The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. JOURNAL OF PHYSIOLOGY-LONDON
- Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
- (2020) Olga Sadowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Animal Models of Hypertension: A Scientific Statement From the American Heart Association
- (2019) Lilach O. Lerman et al. HYPERTENSION
- Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model
- (2019) Laura E. Ewing et al. MOLECULES
- Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
- (2019) Rafał Kossakowski et al. Frontiers in Pharmacology
- A systematic review of cannabidiol dosing in clinical populations
- (2019) S.A. Millar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The protective mechanism of cannabidiol in cardiac injury: A systematic review of non-clinical studies
- (2019) Mohammad Reza Hooshangi Shayesteh et al. CURRENT PHARMACEUTICAL DESIGN
- Beyond THC and Endocannabinoids
- (2019) Pal Pacher et al. Annual Review of Pharmacology and Toxicology
- Italian consensus on treatment of spasticity in multiple sclerosis
- (2019) G. Comi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Gender-specific association between the blood pressure category according to the updated ACC/AHA guidelines for hypertension and cardio-ankle vascular index: a community-based cohort study
- (2019) Tatsuya Kamon et al. Journal of Cardiology
- Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance
- (2018) Barbara Malinowska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Distribution and function of the muscarinic receptor subtypes in the cardiovascular system
- (2018) Hannah C. Saternos et al. PHYSIOLOGICAL GENOMICS
- Cannabinoid CB1 and CB2 receptors antagonists AM251 and AM630 differentially modulate the chronotropic and inotropic effects of isoprenaline in isolated rat atria
- (2018) Jolanta Weresa et al. Pharmacological Reports
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
- (2017) Amanda J. Wheal et al. Frontiers in Pharmacology
- A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
- (2017) Salahaden R. Sultan et al. Frontiers in Pharmacology
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- In vivo Antihypertensive and Antihyperlipidemic Effects of the Crude Extracts and Fractions of Moringa stenopetala (Baker f.) Cufod. Leaves in Rats
- (2016) Bekesho Geleta et al. Frontiers in Pharmacology
- Pharmacologic Effects of Cannabidiol on Acute Reperfused Myocardial Infarction in Rabbits
- (2015) Yuanbo Feng et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Unknown
- (2015) Enkui Hao et al. MOLECULAR MEDICINE
- The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
- (2014) Ersöz Gonca et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses
- (2014) Sarah K. Walsh et al. PLoS One
- Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity
- (2013) Amr A. Fouad et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Myths and realities of the cardiac vagus
- (2013) J. H. Coote JOURNAL OF PHYSIOLOGY-LONDON
- Is the cardiovascular system a therapeutic target for cannabidiol?
- (2012) Christopher P. Stanley et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
- (2010) Sarah K Walsh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation